Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
Novo Nordisk’s European Logistics Breakthrough Meets US Pricing Headwinds
EMA relaxes Wegovy cold-chain rules, cutting EU distribution costs. Novo faces 2026 sales decline from US pricing pressure…